National Seating & Mobility

Bill Mixon has served as CEO since 2014 and continues to lead the company. Ownership is institutional: Cinven, a London-based international private equity firm, acquired a majority stake in February 2024. The previous majority owner was Wellspring Capital Management, a New York-based middle-market private equity firm. NSM operates as a privately held corporation and does not disclose detailed governance beyond its executive leadership team.

Complex rehabilitation technology consists of individually configured power and manual wheelchairs, adaptive seating cushions, and positioning systems designed for people with permanent or long-term physical disabilities. NSM employs ATP-certified (Assistive Technology Professional) clinicians who assess patients in their homes or care facilities, document medical necessity for funding justification, configure the equipment, and coordinate delivery and fitting. The company does not manufacture the devices; it serves as the clinical intermediary and equipment supplier, working with manufacturers such as Permobil, Quantum Rehab, and Sunrise Medical.

NSM is a national provider with more than 180 branch locations across the United States and a small presence in Canada. Its densest coverage areas include the Southeastern states (Tennessee, Georgia, Florida), the Midwest (Ohio, Indiana, Illinois), and Texas. Each branch maintains local ATP-certified staff and relationships with regional payers. The company's Franklin, Tennessee headquarters houses shared clinical compliance, billing, and corporate functions.

A significant portion of the company's operational model is built around navigating payer authorization. NSM's clinical staff produce detailed letters of medical necessity and supporting documentation to secure prior authorization from Medicare, Medicaid, and commercial insurers before equipment is ordered. Revenue cycle management — including initial verification, denial appeals, and post-delivery collections — is a core internal competency. The company's scale provides leverage with major insurers for negotiated in-network rates, though reimbursement rate risk remains an industry-wide pressure point.

NSM is widely regarded as the largest pure-play CRT provider in the U.S. The industry is highly fragmented, with most competitors being single-location or regional durable medical equipment companies. The next-largest scaled competitor is Numotion, which also operates a national network of CRT branches. Privately held brokerages and regional chains such as Reliable Medical Supply and state-level rehabilitation technology programs compete locally, but NSM and Numotion represent the two dominant national consolidators in the space.

Private equity has been the primary source of growth capital for NSM's acquisition strategy. Wellspring Capital Management backed an intensive roll-up of local CRT providers from 2016 to early 2024. Cinven's February 2024 acquisition signals a renewed consolidation mandate, with disclosed plans to pursue additional branch acquisitions, deepen clinical service offerings, and potentially explore operational adjacencies. The firm does not operate or disclose any venture capital or fund-of-funds structures — it is a single-corporate operating entity.

No. NSM is a service, assessment, and distribution company. It does not design, patent, or manufacture wheelchairs or seating components. Its value chain sits between manufacturer and end-user: clinical evaluation, configuration specification, funding navigation, and equipment delivery. The company's moat derives from its ATP-staffed branch network and payer relationships, not from proprietary hardware.